Search Results
397 results
Your search is now limited to «GlaxoSmithKline» expert search.
INTERNATIONAL – GlaxoSmithKline (GSK) chairperson Philip Hampton will step down after more than three and a half years in the role, as Britain’s biggest drugmaker prepares to split its business into two.
More from Business Report (South Africa):
PharmaBiz.com 01/22/2019 05:36
Sir Philip said: “It is a privilege to serve as Chairman of GSK.
More from PharmaBiz.com:
Chairman of GlaxoSmithKline says he will step down.
More from Mail on Sunday (United Kingdom):
LocalTechWire 01/21/2019 13:53
The search is on for the new chairman of pharmaceuticals giant GlaxoSmithKline (GSK.
More from LocalTechWire:
FiercePharmaManufacturing 01/21/2019 07:48
And the goal is to break it off from GSK’s pharma and vaccines franchises, and list it as an independent company in London within three years.
More from FiercePharmaManufacturing:
(MENAFN - GetNews) Worldwidemarketreports.com has launched a new report on the Global Cosmetics and Pharma Market to provide readers with a clear view of the market's likely growth...
More from Middle East North Africa Financial Network (MENAFN):
Pharmafile 01/21/2019 05:20
Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline.
More from Pharmafile:
Reuters.com 01/21/2019 03:04
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018.
More from Reuters.com:
Livemint.com 01/20/2019 22:24
Mehta said the acquisition of GlaxoSmithKline Consumer Healthcare Ltd will not only give it ownership of brands such as Horlicks and Boost, but also strengthen its foods and refreshment segment, where HUL was lagging behind its nearest competitor ITC Ltd for ...
More from Livemint.com:
Business Insider 01/18/2019 12:50
And, Redfern said, having the business as part of GSK gave it more stability, letting the pharma side of the business take more risks.
More from Business Insider:
PharmaTimes 01/16/2019 08:26
GlaxoSmithKline’s (GSK) subsidiary Adriatic Acquisition Corporation (AAC) has extended the expiration date for its tender offer for US-based Tesaro.
More from PharmaTimes:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications